Inoltra – stimulates the regeneration of cartilage tissue, chondroprotective, analgesic, anti-inflammatory.
Inoltra® inhibits processes of degeneration and stimulates processes of cartilage regeneration; maintains elasticity and flexibility of cartilage, filling the deficit of chondroitin sulfate in the main extracellular cartilage matrix, inhibiting synthesis of metalloproteases, PG, antibodies to collagen, inhibiting apoptosis of chondrocytes; It has a stimulating effect on chondrocytes, increases the synthesis of proteoglycans, collagen and hyaluronic acid, increases RNA content in chondrocytes.
Inhibiting inflammation, relieves pain, improves joint mobility in the long term by forming sufficient synovial fluid, increasing its viscosity and suppressing the activity of cartilage-decomposing enzymes. Reduces joint swelling and inflammation, prevents the development of autoimmune diseases (including rheumatoid arthritis); reduces the risk of thrombosis and keeps blood vessel walls in tone. Allows to significantly reduce the dosage or completely refuse taking NSAIDs, which reduces the number of complications from the gastrointestinal tract; combined with other therapies. It is available in Quicksorb Gels™ soft gel capsules, which are quickly and easily digested even by the sensitive digestive tract, do not irritate the stomach and provide maximum absorption of useful substances.
The properties of the ingredients in the product determine their action.
The glucosamines (D-glucosamine sulfate and N-acetyl D-glucosamine) form and support the cartilage matrix structure and ensure its strength, normalize the synovial fluid composition and restore the fluidity and painlessness of movement.
Chondroitin sulfate promotes hydration of cartilage and increases its cushioning ability and anti-inflammatory action.
Eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids suppress autoimmune reactions and reduce swelling in inflammation of the joints (including rheumatoid arthritis).
Gamma-linolenic acid (GLA) has an antiproliferative effect.
The essential omega-3 and omega-6 fatty acids contained in the product are substrates for the synthesis of anti-inflammatory PG1 and PG3 and substrate inhibit the synthesis of inflammatory PG2.
Ascorbyl palmitate (a highly effective fat-soluble form of vitamin C) has antioxidant properties and is involved in the synthesis of collagen, in the formation of chondrocytes, maintaining the structure and functioning of cartilage tissue.
Vitamin E has an independent anti-inflammatory and antioxidant activity, protects against oxidation of PUFAs (EPA, DHA and GLA).
Manganese aspartate promotes better absorption of glucosamine, participates in the absorption of chondroitin sulfate and increases mitochondrial superoxide dismutase activity. Supports osteogenesis, promotes normal metabolism of connective tissue, regeneration and repair of cartilage tissue.
The efficacy and high safety of Inoltra® was proven in a randomized controlled trial on the basis of the rheumatology department of Hospital №2 of the State Medical Center of the Ministry of Health of the Russian Federation.
The use of Inoltra® promoted:
- reduced the severity of pain syndrome in patients with osteoarthritis;
- improved the functional ability of the joints;
- increase in the thickness of the cartilage, which confirms the presence of chondroprotective properties.
.
Indications
Composition
Active substances:
D-glucosamine sulfate500 mg;
N-acetyl-D-glucosamine500 mg;
omega-3 fatty acids;
eicosapentaenoic acid400 mg;
docosahexaenoic acid 300 mg;
omega-6 fatty acids;
gamma-linolenic acid 300 mg;
chondroitin sulfate 200 mg;
Vitamin E (as D-alpha-tocopherol)10 IU;
vitamin C (as ascorbyl palmitate)5 mg;
Manganese aspartate
How to take, the dosage
Overly, 30 minutes before a meal with water.
Adults – 2 capsules 2 times a day or, according to the manufacturer’s recommendations – depending on body weight – 1-3 capsules 3 times a day (patients weighing up to 68 kg – 1 capsule, from 68 to 90 kg – 2 capsules, over 90 kg – 3 capsules).
The duration of treatment is 3-4 months.
If necessary the course of treatment should be repeated.
Consult with the doctor before use.
Special Instructions
Patients should be informed that a physician’s consultation is required before using Inoltra dietary supplements.
It should be noted that the daily amount of herbal ingredients in Inoltra dietary supplements is lower than the doses used for therapeutic purposes.
Contraindications
Pregnancy use
It is contraindicated in pregnancy. Breastfeeding should be stopped during treatment.
Weight | 0.210 kg |
---|---|
Shelf life | 3 years |
Conditions of storage | In a dry place, at a temperature not exceeding 25 °C |
Manufacturer | Irvin Nechurals, USA |
Medication form | capsules |
Brand | Irvin Nechurals |
Related products
Buy Inoltra, capsules, 90 pcs. with delivery to USA, UK, Europe and over 120 other countries.